v1
A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors: Preliminary results
Identifier:nobleid.org/w1/20260515/F3D16DBB
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/F3D16DBB)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims